Peptides for Hypertrophic Scar Treatment: A Targeted Approach

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Hypertrophic scars are raised, red scars confined to the wound area, resulting from excessive collagen deposition. Peptide therapy, using compounds like ADSCP6 and GHRP-6, modulates scar healing by inhibiting collagen overproduction, reducing inflammation, and promoting organized tissue remodeling for a flatter, softer scar.

Peptides for Hypertrophic Scar Treatment: A Targeted Approach

Hypertrophic scars are a common, often frustrating, consequence of skin injury or surgery. These raised, red, and sometimes itchy scars remain confined to the boundaries of the original wound, distinguishing them from keloids, which grow beyond these borders. While not typically a health risk, their appearance can significantly impact a patient's self-esteem and quality of life. Traditional treatments range from corticosteroid injections to laser therapy, but peptide therapy is emerging as a sophisticated, biologically-driven method to modulate scar healing and improve aesthetic outcomes.

The formation of a hypertrophic scar stems from an imbalance in the delicate process of wound healing, specifically an excessive deposition of collagen and a prolonged inflammatory response. This leads to an overabundance of fibroblasts and myofibroblasts—cells that produce and contract scar tissue—and an increase in growth factors like TGF-β1. Peptides, as precise signaling molecules, can intervene in these complex pathways. They work to inhibit excessive collagen production, reduce inflammation, control cell proliferation, and promote the organized remodeling of the extracellular matrix, ultimately aiming for a flatter, softer, and less conspicuous scar.

How Peptides Modulate Hypertrophic Scar Healing

The therapeutic efficacy of peptides in treating hypertrophic scars is rooted in their ability to influence key cellular and molecular processes:

• Anti-fibrotic Action: Peptides can directly reduce the overproduction of collagen and other extracellular matrix components, which are the primary constituents of hypertrophic scars. They also encourage the breakdown of disorganized scar tissue.
• Inflammation Reduction: By dampening the chronic inflammatory signals, peptides help to mitigate the redness and itching often associated with these scars, fostering a calmer healing environment.
• Cell Proliferation Control: They regulate the activity of fibroblasts and myofibroblasts, preventing the excessive cell growth that contributes to scar bulk.
• Extracellular Matrix Remodeling: Peptides facilitate the reorganization of skin components, encouraging the formation of healthier, more structured tissue that more closely resembles normal skin.

Key Peptides for Hypertrophic Scar Treatment

Several peptides have shown significant promise in both research and clinical applications for hypertrophic scar management:

• ADSCP6 Peptide: This peptide has demonstrated a remarkable ability to attenuate fibrotic progression. In studies, ADSCP6 significantly downregulated type I collagen and alpha smooth muscle actin (ACTA2) expression in human hypertrophic scar fibroblasts. This action helps to reduce the excessive fibrous tissue and accelerate wound healing, positioning it as a multifunctional therapeutic agent [1, 2].
• Growth Hormone-Releasing Peptide 6 (GHRP-6): Research, including proteome studies, indicates that GHRP-6 can prevent cutaneous hypertrophic scarring. It appears to modulate wound healing pathways, with evidence suggesting its capacity to prevent and potentially reverse cutaneous fibrosis [3, 4].
• Vimentin-Targeted Peptides: These peptides represent a targeted therapy designed to inhibit the formation of myofibroblasts. Myofibroblasts are critical players in scar contracture and the excessive production of extracellular matrix, making their suppression a strategic approach to mitigating hypertrophic scarring [5].
• Fibromodulin-Based Peptides: Fibromodulin forms a complex that actively prevents myofibroblasts from forming excessive scar tissue. This mechanism helps to improve the organization of the extracellular matrix, leading to a more favorable healing outcome [6, 7].
• Relaxin-2: This peptide promotes regenerative healing and suppresses scar formation. It interferes with dysregulated wound healing processes, including the persistent TGF-β1 signaling and myofibroblast activity that characterize hypertrophic scars, encouraging a more regenerative rather than fibrotic response [8].
• Decorin: A small proteoglycan, Decorin is known to prevent tissue fibrosis and promote tissue regeneration. It achieves this partly by inhibiting TGF-β activity, a key driver of scar formation, thereby contributing to a healthier healing environment [9].

Integrating Peptides into Hypertrophic Scar Management

Peptide therapy can be delivered through various methods. Topical applications, such as creams or gels, are suitable for localized treatment, while direct injections into the scar tissue can provide more targeted and potent effects. You'll find that peptides often work synergistically with established hypertrophic scar treatments, including corticosteroid injections, laser therapy, and silicone sheeting, enhancing their overall efficacy. Early intervention is particularly beneficial; applying peptides during the proliferative phase of scar healing can significantly optimize outcomes.

What You Should Do

If you are dealing with a hypertrophic scar, don't hesitate to seek professional advice. Consult with a dermatologist or plastic surgeon who has expertise in scar management and regenerative medicine. They can assess your specific scar characteristics, discuss the most appropriate peptide therapies, and integrate these advanced compounds into a comprehensive treatment plan tailored to your needs. This proactive approach can lead to significant improvements in scar appearance and function, enhancing your comfort and confidence.

References

1. Li, J. (n.d.). ADSCP6 peptide's role in transforming scar therapy. PubMed.
2. Li, J. (2025). ADSCP6 peptide's role in transforming scar therapy. ScienceDirect.
3. Fernández-Mayola, M., et al. (2018). Growth hormone-releasing peptide 6 prevents cutaneous hypertrophic scarring: early mechanistic data from a proteome study. PMC.
4. Fernández-Mayola, M., et al. (2018). Growth hormone-releasing peptide 6 prevents cutaneous hypertrophic scarring. PubMed.
5. Yale Ventures. (n.d.). VIMENTIN TARGETED THERAPY.
6. UCLA Health. (2025). Researchers may have found a way to mitigate or eliminate.
7. Ethica Cro. (n.d.). Advances Scar Management Injectable Peptide.
8. biorxiv. (2025). Relaxin-2 drives regenerative healing and suppresses scar.
9. PNAS. (n.d.). Target-seeking antifibrotic compound enhances wound.